| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/10/2000 | WO2000046213A2 Method of producing thiobarbituric acid derivatives |
| 08/10/2000 | WO2000046212A1 Method of producing substituted pyrimidine derivatives |
| 08/10/2000 | WO2000046211A1 Method of synthesizing barbituric acid derivatives and their use for the synthesis of chemical libraries |
| 08/10/2000 | WO2000046184A1 N2-phenylamidine derivatives |
| 08/10/2000 | WO2000046182A1 Method of preparing alkylated salicylamides |
| 08/10/2000 | WO2000045819A1 Use of cholesterol-lowering agent |
| 08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
| 08/10/2000 | DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them |
| 08/10/2000 | CA2362085A1 Method of synthesizing barbituric acid derivatives and their use for the synthesis of chemical libraries |
| 08/10/2000 | CA2358641A1 Use of cholesterol-lowering agent |
| 08/09/2000 | EP1026160A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
| 08/09/2000 | EP1026151A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides |
| 08/09/2000 | EP1026143A1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
| 08/09/2000 | EP1025097A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands |
| 08/09/2000 | EP1025091A1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 08/09/2000 | EP1025090A1 Vitronectin receptor antagonists |
| 08/09/2000 | EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/09/2000 | EP0623132B1 Disubstituted polycyclic systems as cognition enhancers |
| 08/09/2000 | CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 08/08/2000 | US6100423 Amino benzenepropanoic acid compounds and derivatives thereof |
| 08/08/2000 | US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/08/2000 | US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents |
| 08/08/2000 | US6100270 Bicyclic heterocyclic compounds for the treatment of impotence |
| 08/08/2000 | US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example |
| 08/08/2000 | US6100257 2-haloalkyl,3-(haloalkyl, alkenyl, or alkynyl),5-(substituted phenyl or heterocycle),6-alkyl-pyrimidin-4-one compounds of given structure; use as herbicides |
| 08/03/2000 | WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents |
| 08/03/2000 | WO2000044727A1 Inhibitors for the biosynthesis of vitamin b2 and method for producing same |
| 08/03/2000 | WO2000044717A2 Synthesis of oligoketides |
| 08/03/2000 | WO2000044227A1 Formulation of herbicides and plant growth regulators |
| 08/03/2000 | WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 08/03/2000 | WO2000031082A8 Pyrimidin-4-enamine as fungicide |
| 08/03/2000 | DE19903736A1 Inhibitoren der Biosynthese von Vitamin B2 und Verfahren zu ihrer Herstellung Inhibitors of the biosynthesis of vitamin B2 and process for their preparation |
| 08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis |
| 08/03/2000 | CA2361040A1 Synthesis of oligoketides |
| 08/02/2000 | EP1022951A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 08/02/2000 | CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use |
| 08/01/2000 | US6096892 Reacting formamide with a dialkyl malonate in an alkanol in the presence of an alkali metal alcholate to form 4,6-dihydroxypyrimidine |
| 08/01/2000 | US6096891 Process for the production of cyclic N,N'-dialkylureas |
| 08/01/2000 | US6096768 Administering a 3, 5, 6-substituted phenyl compound for the treatment of inflammation and autoimmune disorders |
| 08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
| 08/01/2000 | US6096750 Furopyrimidines and methods of making and using the same derivatives |
| 08/01/2000 | US6096749 Pyrrolopyrimidine derivatives having pharmacological activity |
| 08/01/2000 | US6096747 Asthma, antiinflammatory |
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 08/01/2000 | CA2196510C Process for producing dioxoquinazolines |
| 08/01/2000 | CA2015034C Piperazine derivatives |
| 07/27/2000 | WO2000043374A1 Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043372A1 Acyl derivatives which treat vla-4 related disorders |
| 07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043369A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043366A1 Quinoline derivatives and quinazoline derivatives |
| 07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000012500A3 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/26/2000 | EP1022026A2 Pharmaceutical compositions for treating nitrate-induced tolerance |
| 07/26/2000 | EP1021417A1 Substituted phenyluracils |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021412A1 Nitration of aromatic compounds |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021406A1 Novel anandamide amidase inhibitors as analgesic agents |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | EP0755253B1 Intranasal antimigraine composition |
| 07/26/2000 | EP0641781B1 4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof |
| 07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 07/26/2000 | CN1261356A Substituted aminobeterocyclylamides |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/25/2000 | US6093820 Reacting an imide with a (substituted)alkoxyalkylsulfonic acid ester to form a n-alkoxyalkyl imide such as methoxymethyl ethosuximide; administering as anticonvulsant, antianxiety agent and muscle relaxant |
| 07/25/2000 | US6093718 An oxido-squalene cyclase inhibitor, anticholesterol agent for inhibiting cholesterol biosynthesis and lowering cholesterol levels in blood plasma; treating hypercholesterolemia and atherosclerosis |
| 07/25/2000 | US6093345 Optically active compound, liquid crystal composition containing the same, and liquid crystal electro-optic element using the same |
| 07/25/2000 | CA2272597A1 Quaternary ammonium salts of sulfonylurea |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042025A1 Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives |
| 07/20/2000 | WO2000042024A1 Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt |
| 07/20/2000 | WO2000042007A1 Alfa-sulfenimino acid derivatives |
| 07/20/2000 | WO2000041999A1 Oxime derivatives and uses thereof |
| 07/20/2000 | WO2000041998A1 Novel propargylether derivatives |
| 07/20/2000 | WO2000003709A9 Novel dna-cleaving antitumor agents |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020423A1 Fluoroalkoxybenzene derivatives having ether bond, liquid-crystal composition, and liquid-crystal display element |
| 07/19/2000 | EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/19/2000 | EP0592680B1 N-sulfonated carboxamide derivatives as fungicides for plants |
| 07/19/2000 | CN1260785A Method for producing quinazoline-diones in solid phase and use of the same |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
| 07/18/2000 | US6090941 Pharmaceutically active benzoquinazoline compounds |
| 07/18/2000 | US6090836 Benzisoxazole-derived antidiabetic compounds |